369
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Sociodemographic patterns in biomarkers of aging in the Add Health cohort

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Aiello, A. E., M. N. Haan, L. Blythe, K. Moore, J. M. Gonzalez, and W. Jagust. 2006. The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatrics Society 54 (7) (July 1):1046–54. doi:10.1111/j.1532-5415.2006.00796.x.
  • Bagby, S. P., D. Martin, S. T. Chung, and N. Rajapakse. 2019. From the outside In: Biological mechanisms linking social and environmental exposures to chronic disease and to health disparities. American Journal of Public Health 109 (S1) (January 1):S56–63. doi:10.2105/AJPH.2018.304864.
  • Bailey, Z. D., N. Krieger, M. Agénor, J. Graves, N. Linos, and M. T. Bassett. 2017. Structural racism and health inequities in the USA: Evidence and interventions. Lancet 389 (10077) (April 8):1453–63. doi:10.1016/S0140-6736(17)30569-X.
  • Beydoun, M. A., H. A. Beydoun, M. R. Shroff, M. H. Kitner-Triolo, and A. B. Zonderman. 2013. Helicobacter Pylori seropositivity and cognitive performance among US adults: Evidence from a large national survey. Psychosomatic Medicine 75 (5):486–96. doi:10.1097/PSY.0b013e31829108c3.
  • Bruunsgaard, H., M. Pedersen, and B. K. Pedersen. 2001. Aging and proinflammatory cytokines. Current Opinion in Hematology 8 (3):131–36. doi:10.1097/00062752-200105000-00001.
  • Bucholz, E. M., H. C. Gooding, and S. D. de Ferranti. 2018. Awareness of cardiovascular risk factors in U.S. Young adults aged 18–39 years. American Journal of Preventive Medicine 54 (4) (April 1):e67–77. doi:10.1016/j.amepre.2018.01.022.
  • Casas, J. P., T. Shah, A. D. Hingorani, J. Danesh, and M. B. Pepys. 2008. C-Reactive protein and coronary heart disease: A critical review. Journal of Internal Medicine 264 (4) (October 1):295–314. doi:10.1111/j.1365-2796.2008.02015.x.
  • Centers for Disease Control and Prevention. 2022. Defining Adult Overweight & Obesity | Overweight & Obesity | CDC. https://www.cdc.gov/obesity/basics/adult-defining.html.
  • Chen, X., E. Crimmins, P. (Perry) Hu, J. K. Kim, Q. Meng, J. Strauss, Y. Wang, J. Zeng, Y. Zhang, and Y. Zhao. 2019. Venous blood-based biomarkers in the china health and retirement longitudinal study: Rationale, design, and results from the 2015 wave. American Journal of Epidemiology 188 (11) (November 1):1871–77. doi:10.1093/aje/kwz170.
  • Chen, P., and K. M. Harris. 2020. Construction of wave V biomarker weight.
  • Danesh, J., J. G. Wheeler, G. M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. D. O. Lowe, M. B. Pepys, and V. Gudnason. 2004. C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine 350 (14) (April 1):1387–97. doi:10.1056/NEJMoa032804.
  • de Wolf, F., M. Ghanbari, S. Licher, K. McRae-McKee, L. Gras, G. J. Weverling, P. Wermeling, S. Sedaghat, M. K. Ikram, and R. Waziry. 2020. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study. Brain A Journal of Neurology 143 (4):1220–32. doi:10.1093/brain/awaa054.
  • Dhabhar, F. S., H. M. Burke, E. S. Epel, S. H. Mellon, R. Rosser, V. I. Reus, and O. M. Wolkowitz. 2009. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. Journal of Psychiatric Research 43 (11):962–69. doi:10.1016/j.jpsychires.2009.05.010.
  • Dowd, J. B., A. Zajacova, and A. E. Aiello. 2010. Predictors of inflammation in U.S. Children aged 3–16 years. American Journal of Preventive Medicine 39 (4) (October 1):314–20. doi:10.1016/j.amepre.2010.05.014.
  • Du Clos, T. W. 2000. Function of C-Reactive protein. Annals of Medicine 32 (4) (January 1):274–78. doi:10.3109/07853890009011772.
  • Engelhart, M. J., M. I. Geerlings, J. Meijer, A. Kiliaan, A. Ruitenberg, J. C. van Swieten, T. Stijnen, A. Hofman, J. C. M. Witteman, and M. M. B. Breteler. 2004. Inflammatory proteins in plasma and the risk of dementia: The Rotterdam study. Archives of Neurology 61 (5) (May 1):668–72. doi:10.1001/archneur.61.5.668.
  • Everett, B., and A. Zajacova. 2015. Gender differences in hypertension and hypertension awareness among young adults. Biodemography and Social Biology 61 (1) (January 2):1–17. doi:10.1080/19485565.2014.929488.
  • Ferrucci, L., and E. Fabbri. 2018. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nature Reviews Cardiology 15 (9) (September 1):505–22. doi:10.1038/s41569-018-0064-2.
  • Furman, D., J. Campisi, E. Verdin, P. Carrera-Bastos, S. Targ, C. Franceschi, L. Ferrucci, D. W. Gilroy, A. Fasano, G. W. Miller, et al. 2019. Chronic inflammation in the etiology of disease across the life span. Nature Medicine 25 (12) (December 1):1822–32. doi:10.1038/s41591-019-0675-0.
  • Global Burden of Disease Obesity Collaborators. 2017. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine 377 (1) (July 6): 13–27. 10.1056/NEJMoa1614362
  • Gooding, H. C., S. McGinty, T. K. Richmond, M. W. Gillman, and A. E. Field. 2014. Hypertension awareness and control among young adults in the national longitudinal study of adolescent health. Journal of General Internal Medicine 29 (8) (August 1):1098–104. doi:10.1007/s11606-014-2809-x.
  • Grivennikov, S. I., F. R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell 140, (6) (March 19):883–99. doi:10.1016/j.cell.2010.01.025.
  • Hansson, O. 2021. Biomarkers for neurodegenerative diseases. Nature Medicine 27 (6) (June 1):954–63. doi:10.1038/s41591-021-01382-x.
  • Harris, K. M., C. T. Halpern, E. A. Whitsel, J. M. Hussey, L. A. Killeya-Jones, J. Tabor, and S. C. Dean. 2019. Cohort profile: The national longitudinal study of adolescent to adult health (add health). International Journal of Epidemiology 48 (5) (October 1):1415–1415k. doi:10.1093/ije/dyz115.
  • Harris, K. M., and T. W. McDade. 2018. The biosocial approach to human development, behavior, and health across the life course. RSF: The Russell Sage Foundation Journal of the Social Sciences 4 (4) (April 1):2. doi:10.7758/RSF.2018.4.4.01.
  • Harris, K. M., and K. M. Schorpp. 2018. Integrating biomarkers in social stratification and health research. Annual Review of Sociology 44 (1):361–86. doi:10.1146/annurev-soc-060116-053339.
  • Hatch, S. L., and B. P. Dohrenwend. 2007. Distribution of traumatic and other stressful life events by race/ethnicity, gender, SES and age: A review of the research. American Journal of Community Psychology 40 (3–4) (December 1):313–32. doi:10.1007/s10464-007-9134-z.
  • Heneka, M. T., M. P. Kummer, and E. Latz. 2014. Innate immune activation in neurodegenerative disease. Nature Reviews Immunology 14 (7) (July 1):463–77. doi:10.1038/nri3705.
  • Holm, S. 1979. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6 (2):65–70. JSTOR.
  • Ikram, M. A., G. G. O. Brusselle, S. D. Murad, C. M. van Duijn, O. H. Franco, A. Goedegebure, C. C. W. Klaver, T. E. C. Nijsten, R. P. Peeters, B. H. Stricker, et al. 2017. The Rotterdam study: 2018 update on objectives, design and main results. European Journal of Epidemiology 32 (9) (September 1):807–50. doi:10.1007/s10654-017-0321-4.
  • Khalil, M., L. Pirpamer, E. Hofer, M. M. Voortman, C. Barro, D. Leppert, P. Benkert, S. Ropele, C. Enzinger, F. Fazekas, et al. 2020. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nature communications 11 (1) (February 10):812. doi:10.1038/s41467-020-14612-6.
  • Khalil, M., C. E. Teunissen, M. Otto, F. Piehl, M. P. Sormani, T. Gattringer, C. Barro, L. Kappos, M. Comabella, F. Fazekas, et al. 2018. Neurofilaments as biomarkers in neurological disorders. Nature Reviews Neurology 14 (10) (October 1):577–89. doi:10.1038/s41582-018-0058-z.
  • Koini, M., L. Pirpamer, E. Hofer, A. Buchmann, D. Pinter, S. Ropele, C. Enzinger, P. Benkert, D. Leppert, and J. Kuhle. 2021. Factors influencing serum neurofilament light chain levels in normal aging. Aging (Albany NY) 13 (24):25729. doi:10.18632/aging.203790.
  • Liu, R. S., A. E. Aiello, F. K. Mensah, C. E. Gasser, K. Rueb, B. Cordell, M. Juonala, M. Wake, and D. P. Burgner. 2017. Socioeconomic status in childhood and C reactive protein in adulthood: A systematic review and meta-analysis. Journal of Epidemiology and Community Health 71 (8):817–26. doi:10.1136/jech-2016-208646.
  • Locascio, J. J., H. Fukumoto, L. Yap, T. Bottiglieri, J. H. Growdon, B. T. Hyman, and M. C. Irizarry. 2008. Plasma amyloid β-protein and C-Reactive protein in relation to the rate of progression of Alzheimer disease. Archives of Neurology 65 (6) (June 1):776–85. doi:10.1001/archneur.65.6.776.
  • Long, J. S. 1997. Regression Models for Categorical and Limited Dependent Variables/J. Scott Long. Advanced Quantitative Techniques in the Social Sciences Series. Newbury Park, Calif. u.a. http://media.obvsg.at/AC02009995-1001, https://www.oeaw.ac.at/resources/Record/990000735210504498.
  • McDade, T. 2011. The state and future of blood-based biomarkers in the health and retirement study. Forum for Health Economics & Policy 14 (2). doi: 10.2202/1558-9544.1263.
  • Michaud, M., L. Balardy, G. Moulis, C. Gaudin, C. Peyrot, B. Vellas, M. Cesari, and F. Nourhashemi. 2013. Proinflammatory cytokines, aging, and age-related diseases. Journal of the American Medical Directors Association 14 (12) (December 1):877–82. doi:10.1016/j.jamda.2013.05.009.
  • Muscatell, K. A., S. N. Brosso, and K. L. Humphreys. 2020. Socioeconomic status and inflammation: A meta-analysis. Molecular Psychiatry 25 (9) (September 1):2189–99. doi:10.1038/s41380-018-0259-2.
  • National Academies of Sciences, E., and Medicine. 2021. Division of behavioral and social sciences and education; committee on national statistics; committee on population; committee on rising midlife mortal‑ity rates and socioeconomic disparities. High and rising mortality rates among working‑age adults. In High and rising mortality rates among working-age adults, T. Becker, M. Majmundar, K. Harris ed.
  • Pase, M. P., A. S. Beiser, J. J. Himali, C. L. Satizabal, H. J. Aparicio, C. DeCarli, G. Chêne, C. Dufouil, and S. Seshadri. 2019. Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes. JAMA Neurology 76 (5):598–606. doi:10.1001/jamaneurol.2018.4666.
  • Pawelec, G., D. Goldeck, and E. Derhovanessian. 2014. Inflammation, ageing and chronic disease. Host Pathogens * Immune Senescence 29 (August 1):23–28. doi:10.1016/j.coi.2014.03.007.
  • Rajan, K. B., N. T. Aggarwal, E. A. McAninch, J. Weuve, L. L. Barnes, R. S. Wilson, C. DeCarli, and D. A. Evans. 2020. Remote blood biomarkers of longitudinal cognitive outcomes in a population study. Annals of Neurology 88 (6) (December 1):1065–76. doi:10.1002/ana.25874.
  • Ravaglia, G., P. Forti, F. Maioli, M. Chiappelli, F. Montesi, E. Tumini, E. Mariani, F. Licastro, and C. Patterson. 2007. Blood inflammatory markers and risk of dementia: The conselice study of brain aging. Neurobiology of Aging 28 (12) (December 1):1810–20. doi:10.1016/j.neurobiolaging.2006.08.012.
  • Rebelos, E., E. Rissanen, M. Bucci, O. Jääskeläinen, M.-J. Honka, L. Nummenmaa, D. Moriconi, S. Laurila, P. Salminen, S.-K. Herukka, et al. 2022. Circulating neurofilament is linked with morbid obesity, renal function, and brain density. Scientific Reports 12 (1) (May 12):7841. doi:10.1038/s41598-022-11557-2.
  • Rodríguez-Hernández, H., L. E. Simental-Mendía, G. Rodríguez-Ramírez, and M. A. Reyes-Romero. 2013. Obesity and inflammation: Epidemiology, risk factors, and markers of inflammation. Ed. Abdelfattah El Ouaamari. International Journal of Endocrinology 2013 (April 17):678159. doi:10.1155/2013/678159.
  • Rubio-Perez, J. M., and J. M. Morillas-Ruiz. 2012. A review: Inflammatory process in Alzheimer’s disease, role of cytokines. Ed. Toshio Kawamata. Scientific World Journal 2012 (April 1): 756357. doi:10.1100/2012/756357.
  • Rübsamen, N., A. Maceski, D. Leppert, P. Benkert, J. Kuhle, H. Wiendl, A. Peters, A. Karch, and K. Berger. 2021. Serum neurofilament light and tau as prognostic markers for all-cause mortality in the elderly general population—an analysis from the MEMO study. BMC Medicine 19 (1) (February 15):38. doi:10.1186/s12916-021-01915-8.
  • Ryff, C. D., T. Seeman, and M. Weinstein. 2019. Midlife in the United States (MIDUS 2): Biomarker project, 2004-2009. Inter-University Consortium for Political and Social Research distributor.
  • Savoia, C., and E. L. Schiffrin. 2006. Inflammation in hypertension. Current Opinion in Nephrology and Hypertension 15 (2):152–58. doi:10.1097/01.mnh.0000203189.57513.76.
  • Shaw, L. M., M. Korecka, C. M. Clark, V. M.-Y. Lee, and J. Q. Trojanowski. 2007. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics. Nature Reviews Drug Discovery 6 (4) (April 1):295–303. doi:10.1038/nrd2176.
  • Singh, T., and A. B. Newman. 2011. Inflammatory markers in population studies of aging. Ageing Research Reviews 10 (3):319–29. doi:10.1016/j.arr.2010.11.002.
  • Soysal, P., F. Arik, L. Smith, S. E. Jackson, and A. T. Isik. 2020. Inflammation, frailty and cardiovascular disease. In Frailty and cardiovascular diseases : Research into an elderly population, ed. N. Veronese, 55–64. Cham: Springer International Publishing. doi:10.1007/978-3-030-33330-0_7.
  • Stebbins, R. C., J. K. Edwards, B. L. Plassman, Y. C. Yang, G. A. Noppert, M. Haan, and A. E. Aiello. 2021. Immune function, cortisol, and cognitive decline & dementia in an aging latino population. Psychoneuroendocrinology 133 (November):105414. doi:10.1016/j.psyneuen.2021.105414.
  • Suzman, R. 2009. The national social life, health, and aging project: An introduction. The Journals of Gerontology: Series B 64B (suppl_1) (November 1):i5–11. doi:10.1093/geronb/gbp078.
  • Teunissen, C. E., M. P. J. van Boxtel, H. Bosma, E. Bosmans, J. Delanghe, C. De Bruijn, A. Wauters, M. Maes, J. Jolles, H. W. M. Steinbusch, et al. 2003. Inflammation markers in relation to cognition in a healthy aging population. Journal of Neuroimmunology 134 (1) (January 1):142–50. doi:10.1016/S0165-5728(02)00398-3.
  • Tobin, J. 1958. Estimation of relationships for limited dependent variables. Econometrica 26 (1) JSTOR:24–36. doi:10.2307/1907382.
  • Walker, K. A., B. N. Ficek, and R. Westbrook. 2019. Understanding the role of systemic inflammation in Alzheimer’s disease. ACS chemical neuroscience 10 (8) (August 21):3340–42. doi:10.1021/acschemneuro.9b00333.
  • Whitsel, E. A., R. Angel, R. O’Hara, L. Qu, K. Carrier, and K. M. Harris. 2022a. Add Health Wave V Documentation: Inflammation and Immune Function. doi:10.17615/99s8-5w62.
  • Whitsel, E. A., R. Angel, R. O’Hara, L. Qu, K. Carrier, and K. M. Harris. 2022b. Add Health Wave V Documentation: Neurodegeneration. doi:10.17615/3qsg-z237.
  • Willerson, J. T., and P. M. Ridker. 2004. Inflammation as a Cardiovascular Risk Factor. Circulation 109 (21_suppl_1) (June 1):II–2. doi:10.1161/01.CIR.0000129535.04194.38.
  • Williams, D. R., J. A. Lawrence, and B. A. Davis. 2019. Racism and health: Evidence and needed research. Annual Review of Public Health 40 (1) (April 1):105–25. doi:10.1146/annurev-publhealth-040218-043750.
  • Zetterberg, H. 2019. Blood-based biomarkers for Alzheimer’s disease—an update. Journal of Neuroscience Methods 319:2–6. doi:10.1016/j.jneumeth.2018.10.025.